Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
MR

MRNA

Market Closed

Moderna, Inc.

NASDAQHealthcareBiotechnology
US
4.70K employees
CEO: Stéphane Bancel
Founded: 2018
$215.79
+$0.00(+NaN%)
Market Cap
87.31B
Beta
0.90
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Moderna's current price at $254.19 vastly exceeds the PERT-weighted fair value of $28.20, indicating significant overvaluation with an implied downside near 89%. Valuation methods, especially DCF analysis, suggest negligible intrinsic value, while financial health scores highlight strong liquidity but zero profitability and efficiency. Monte Carlo analysis shows no downside scenarios below the current price, signaling high risk despite liquidity strength.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore MRNA

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

MRNA in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →